Cytori Cell Research Institute, Inc. (3750.T)
JPY 916.0
(-1.51%)
JPY 916.0
(-1.51%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 15.47 JPY | 113.02% |
| 2022 | -118.71 JPY | -1250.51% |
| 2021 | -8.79 JPY | 91.35% |
| 2020 | -101.64 JPY | -313.89% |
| 2019 | 47.52 JPY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -27.10 JPY | -135.07% |
| 2023 Q2 | -31.59 JPY | -74.92% |
| 2023 Q1 | -18.06 JPY | 52.44% |
| 2023 Q4 | 77.28 JPY | 731.37% |
| 2023 Q3 | -12.24 JPY | 61.25% |
| 2023 FY | - JPY | 113.02% |
| 2022 Q3 | -18.09 JPY | 41.0% |
| 2022 FY | - JPY | -1250.51% |
| 2022 Q4 | -37.97 JPY | -109.89% |
| 2022 Q2 | -30.66 JPY | 0.0% |
| 2021 FY | - JPY | 91.35% |
| 2020 FY | - JPY | -313.89% |
| 2019 FY | - JPY | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 92.20 JPY | 83.221% |
| PRISM BioLab Co.,LTD | -14.90 JPY | 203.826% |
| GNI Group Ltd. | 169.50 JPY | 90.873% |
| Linical Co., Ltd. | 14.98 JPY | -3.271% |
| Trans Genic Inc. | 0.24 JPY | -6345.833% |
| MEDINET Co., Ltd. | -6.65 JPY | 332.632% |
| Soiken Holdings Inc. | -25.32 JPY | 161.098% |
| AnGes, Inc. | -39.29 JPY | 139.374% |
| OncoTherapy Science, Inc. | -6.05 JPY | 355.702% |
| Nxera Pharma Co., Ltd. | -87.17 JPY | 117.747% |
| Immuno-Biological Laboratories Co., Ltd. | 20.05 JPY | 22.843% |
| NanoCarrier Co., Ltd. | -11.10 JPY | 239.369% |
| Carna Biosciences, Inc. | -68.62 JPY | 122.544% |
| CanBas Co., Ltd. | -67.87 JPY | 122.794% |
| D. Western Therapeutics Institute, Inc. | -25.56 JPY | 160.524% |
| RaQualia Pharma Inc. | -14.98 JPY | 203.271% |
| Chiome Bioscience Inc. | -24.62 JPY | 162.835% |
| Kidswell Bio Corporation | -40.23 JPY | 138.454% |
| PeptiDream Inc. | 23.41 JPY | 33.917% |
| Oncolys BioPharma Inc. | -108.92 JPY | 114.203% |
| Ribomic Inc. | -28.70 JPY | 153.902% |
| SanBio Company Limited | -40.48 JPY | 138.216% |
| Healios K.K. | -56.22 JPY | 127.517% |
| BrightPath Biotherapeutics Co., Ltd. | -18.21 JPY | 184.953% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -26.79 JPY | 157.745% |
| Delta-Fly Pharma, Inc. | -198.72 JPY | 107.785% |
| StemRIM | -32.98 JPY | 146.907% |
| CellSource Co., Ltd. | 48.88 JPY | 68.351% |
| FunPep Company Limited | -39.63 JPY | 139.036% |
| Kringle Pharma, Inc. | -158.46 JPY | 109.763% |
| Stella Pharma Corporation | -24.66 JPY | 162.733% |
| TMS Co., Ltd. | -26.02 JPY | 159.454% |
| Noile-Immune Biotech Inc. | -27.25 JPY | 156.771% |
| Cuorips Inc. | -85.87 JPY | 118.016% |
| K Pharma,Inc. | 22.43 JPY | 31.03% |
| Takara Bio Inc. | 12.29 JPY | -25.875% |
| ReproCELL Incorporated | -0.37 JPY | 4281.081% |
| PhoenixBio Co., Ltd. | 6.88 JPY | -124.855% |
| StemCell Institute Inc. | 30.25 JPY | 48.86% |
| Japan Tissue Engineering Co., Ltd. | 3.53 JPY | -338.244% |
| CellSeed Inc. | -29.43 JPY | 152.565% |